We analyzed the clinical data including age, sex, leukocyte count, hemoglobin count, thrombocyte count, cytogenetic abnormality, BCR-ABL1 FISH signal pattern and splenomegaly, in 17 CML-BP patients and 52 ALL patients. This evidence concerns the gene BCR and acute lymphoblastic leukemia.